Evidence map›Paper›PMID 38429821›Full record

ArticleJournal of translational medicine2024

Gut microbiota dynamics and fecal SCFAs after colonoscopy: accelerating microbiome stabilization by Clostridium butyricum.

Zhenhui Chen, Lu Yu, Jiaxin Liu, Jingjing Kong, Xiaoshi Deng, Xiaotong Guo, Jiamin Shan, Daixuan Zhou, Wendan Li, Yangfan Lin and 5 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
  6. Article
  7. Review
  8. Frontiers in veterinary science · 2025
    Article
  9. Article
  10. Review
  11. Opportunistic Features of Non-Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhenhui Chen *Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Lu Yu *Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jiaxin Liu *Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Jingjing KongDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Xiaoshi DengDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Xiaotong GuoDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Jiamin ShanDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Daixuan ZhouGuangdong Provincial Key Laboratory of Gastroenterology, Inst. Of Gastroenterology of Guangdong Province, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wendan LiDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Yangfan LinGuangdong Provincial Key Laboratory of Gastroenterology, Inst. Of Gastroenterology of Guangdong Province, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wanwen HuangDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Weisen ZengDepartment of Cell Biology, School of Basic Medicine, Southern Medical University, Guangzhou, China.
Xinlong ShiDepartment of Colorectal Surgery, Gansu Provincial Hospital, Lanzhou, China.
Yang BaiGuangdong Provincial Key Laboratory of Gastroenterology, Inst. Of Gastroenterology of Guangdong Province, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China. baiyang1030@hotmail.com.
Hongying FanDepartment of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China. gzfhy@smu.edu.cn.ORCID 0000-0002-0725-1596

Funding

Key-Areas Research and Development Programs of Guangdong Province 2022B1111070006National Natural Science Foundation of China 32300085National Natural Science Foundation of China 32370139&32070118Natural Science Foundation of Gansu Province 21JR7RA624the Clinical Research Project of Nanfang Hospital 2021CR008
6 · The paper itself

Abstract

backgroundColonoscopy is a classic diagnostic method with possible complications including abdominal pain and diarrhoea. In this study, gut microbiota dynamics and related metabolic products during and after colonoscopy were explored to accelerate gut microbiome balance through probiotics.

methodsThe gut microbiota and fecal short-chain fatty acids (SCFAs) were analyzed in four healthy subjects before and after colonoscopy, along with seven individuals supplemented with Clostridium butyricum. We employed 16S rRNA sequencing and GC-MS to investigate these changes. We also conducted bioinformatic analysis to explore the buk gene, encoding butyrate kinase, across C. butyricum strains from the human gut.

resultsThe gut microbiota and fecal short-chain fatty acids (SCFAs) of four healthy subjects were recovered on the 7th day after colonoscopy. We found that Clostridium and other bacteria might have efficient butyric acid production through bioinformatic analysis of the buk and assessment of the transcriptional level of the buk. Supplementation of seven healthy subjects with Clostridium butyricum after colonoscopy resulted in a quicker recovery and stabilization of gut microbiota and fecal SCFAs on the third day.

conclusionWe suggest that supplementation of Clostridium butyricum after colonoscopy should be considered in future routine clinical practice.

Indexed as

Clostridium butyricumGastrointestinal MicrobiomeMicrobiotaButyric AcidColonoscopyFatty Acids, VolatileHumansRNA, Ribosomal, 16SButyric AcidFatty Acids, VolatileRNA, Ribosomal, 16SClostridium butyricumColonoscopyGut microbiomeProbioticsShort-chain fatty acids

Identifiers

PMID38429821
PMCPMC10908214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.